# GinkgoPharma(Suzhou)Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ginkgopharma-suzhou-co

- Industry: Pharmaceuticals
- Headquarters: Suzhou, China
- Website: www.ginkgopharma.com
- Total disclosed funding: $20M
- Latest round: Series B (Jun 23, 2017)
- Investors on record: 6

## About

Established in 2009 and based in Suzhou, China, GinkgoPharma(Suzhou)Co., Ltd is a biotechnology company that focuses on the research and development of novel treatments for hepatitis virus.

## Funding rounds

- Series B, Jun 23, 2017, $20M — Lilly Asia Ventures, Cowin Capital, Kaitai Capital, Shiyu Capital
- Series A, Oct 12, 2015 — Lilly Asia Ventures, Kawin Technology, Ginkgo Gofar Group

## Investors

- Lilly Asia Ventures (https://capitalatlas.ai/funds/lilly-asia-ventures) — Series A, Series B
- Kawin Technology — Series A
- Ginkgo Gofar Group — Series A
- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Series B
- Kaitai Capital (https://capitalatlas.ai/funds/kaitai-capital) — Series B
- Shiyu Capital (https://capitalatlas.ai/funds/shiyu-capital) — Series B